Published in Medical Imaging Business Week, March 1st, 2007
This trend article about University of Tsukuba, Japan, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Scientists discuss in "The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE" new findings in prostate cancer. "We analyzed the outcome of primary androgen depletion therapy, which has gained more attention as a potential therapeutic option in patients with localized or locally advanced prostate cancer as it has been increasingly implemented despite limited data on its therapeutic impact...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.